Table 2

Survival analysis for different subgroups

GroupsMedian survival months
Nuclear expressionNo nuclear expressionp‐value
YB‐15 (37)13 (40)p<0.0001
 Stages I–III group8 (14)17 (24)p<0.003
 Stage IV group2 (23)6 (16)p<0.013
 Therapy group5 (29)15 (36)p<0.005
 Best supportive care2 (8)3 (4)ns
 p53wt and5 (14)15 (23)
  p53mut3 (23)13 (17)p<0.0001
 p53pos and3 (17)4 (24)
  p53neg8 (20)12 (16)p<0.0001
  • Data are presented as months survival (total n)

  • p‐value derived from Log rank-Mantel-Cox-Test

  • ns: nonsignificant